CompletedNCT02746367
Validating a Blood Marker Panel for Depression and Bipolarity
About this title
Read the official source — NCT02746367Observational studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Iowa City and 4 more locationsSee all locations and recruitment
Study information
Study start dateMarch 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 261
- Sponsor
- Myriad Genetic Laboratories, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Observational
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02746367
- Official title
Show the full official title
A Validation Study to Measure the Impact of a Proteomic Assay in Distinguishing Bipolar I Disorder, Bipolar II Disorder, and Major Depressive Disorder in People Presenting With a Major Depressive Episode
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Iowa City · Minneapolis · Mason
2 more locations
- Pittsburgh
- San Antonio
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Myriad Genetic Laboratories, Inc., a pharmaceutical company.
Who was this study for?
Listed age limits: 18 years to 70 years.
